Merck Sharp & Dohme Corp. (MRK)

Biotech M&A has hit a record pace in 2026, with deal value reaching $216 billion so far this year, up from $118 billion over the same stretch last year, according to LSEG data.

Cliff Asness is a billionaire investor and the co-founder and chief investment officer of AQR Capital Management, a quantitative hedge fund.

Dividend stocks have long been a favorite among investors focused on building wealth over time.

TheFly reported on June 18 that MRK announced that the U.S.

The anti-obesity drug (AOM) market in the United States is rapidly changing structurally.

Kevin O’Leary’s public investing persona has long leaned toward businesses with cash generation, shareholder returns, and financial discipline rather than high-risk growth stories.

Counter-cyclical stocks are getting more attention as investors look for businesses tied to demand that does not disappear just because the economy slows.

In a recent episode of the Market Insights podcast, Fisher Investments Founder, Executive Chairman, and Co-Chief Investment Officer Ken Fisher addressed a new set of listener questions.

Merck & Co., Inc. (NYSE:MRK) is one of the best cheap stocks to buy for beginners. Moderna, Inc. and Merck & Co., Inc.